Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada
Source: SeekingAlpha
2025-03-24 08:19:22 ET
More on Sunshine Biopharma
- Seeking Alpha’s Quant Rating on Sunshine Biopharma
- Historical earnings data for Sunshine Biopharma
- Financial information for Sunshine Biopharma
Read the full article on Seeking Alpha
For further details see:
Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada
Sunshine Biopharma Inc.
NASDAQ: SBFM
SBFM Trading
0.0% G/L:
$1.19 Last:
15,648 Volume:
$1.18 Open:
SBFM Latest News
October 28, 2025 02:10:00 pm
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
October 28, 2025 07:45:00 am
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
October 20, 2025 07:45:00 am
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
October 16, 2025 09:30:04 am
Molecules, Machines & Markets: Biotech Booms, AI Accelerates, and Pain Relief Gets Personal
SBFM Stock Data
$5,421,575
4,505,830
0.12%
10
N/A
Pharmaceuticals
Healthcare
CA
Fort Lauderdale
